+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446070
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Aldagen
  • Arteriocyte
  • CordVida
  • Cytori Therapeutics
  • LifeCell International
  • Stem Cyte
Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth and Change to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global stem cell/cord blood banking market.







The report focuses on the stem cell/cord blood banking market which is experiencing strong growth. The report gives a guide to the stem cell/cord blood banking market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for stem cell/cord blood banking? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Stem Cell/Cord Blood Banking Market Global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope


Markets Covered:


  • By Cell Type: Adult Stem Cells; Umbilical Cord Blood Stem Cells; Embryonic Stem Cells
  • By Service: Collection; Processing; Analysis; Storage
  • By Bank Type: Public; Private
  • By Application: Leukemia; Anemia; Thalassemia; Autism; Cerebral Palsy; Diabetes; Others

Companies Mentioned:


AMAG Pharmaceuticals; Cordlife; Cryo-Cell International; Esperite; Americord Registry LLC

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data Segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Stem Cell/Cord Blood Banking Market

What is the estimated value of the Global Stem Cell/Cord Blood Banking Market?

The Global Stem Cell/Cord Blood Banking Market was estimated to be valued at $8.6 billion in 2021.

What is the growth rate of the Global Stem Cell/Cord Blood Banking Market?

The growth rate of the Global Stem Cell/Cord Blood Banking Market is 9.8%, with an estimated value of $12.5 billion by 2025.

What is the forecasted size of the Global Stem Cell/Cord Blood Banking Market?

The Global Stem Cell/Cord Blood Banking Market is estimated to be worth $12.5 billion by 2025.

Who are the key companies in the Global Stem Cell/Cord Blood Banking Market?

Key companies in the Global Stem Cell/Cord Blood Banking Market include AMAG Pharmaceuticals, Cordlife, Cryo, Cell International, Esperite, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Limited and ESPERITE N.V..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aldagen
  • Arteriocyte
  • CordVida
  • Cytori Therapeutics
  • LifeCell International
  • Stem Cyte

1. Executive Summary2. Stem Cell/Cord Blood Banking Market Characteristics3. Stem Cell/Cord Blood Banking Market Trends and Strategies4. Impact Of COVID-19 On Stem Cell/Cord Blood Banking
5. Stem Cell/Cord Blood Banking Market Size and Growth
5.1. Global Stem Cell/Cord Blood Banking Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Stem Cell/Cord Blood Banking Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Stem Cell/Cord Blood Banking Market Segmentation
6.1. Global Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Adult Stem Cells
  • Umbilical Cord Blood Stem Cells
  • Embryonic Stem Cells
6.2. Global Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Collection
  • Processing
  • Analysis
  • Storage
6.3. Global Stem Cell/Cord Blood Banking Market, Segmentation by Bank Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Public
  • Private
6.4. Global Stem Cell/Cord Blood Banking Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Leukemia
  • Anemia
  • Thalassemia
  • Autism
  • Cerebral palsy
  • Diabetes
  • Others

7. Stem Cell/Cord Blood Banking Market Regional and Country Analysis
7.1. Global Stem Cell/Cord Blood Banking Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Stem Cell/Cord Blood Banking Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Stem Cell/Cord Blood Banking Market
8.1. Asia-Pacific Stem Cell/Cord Blood Banking Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Stem Cell/Cord Blood Banking Market
9.1. China Stem Cell/Cord Blood Banking Market Overview
9.2. China Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Stem Cell/Cord Blood Banking Market
10.1. India Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Stem Cell/Cord Blood Banking Market
11.1. Japan Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Stem Cell/Cord Blood Banking Market
12.1. Australia Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Stem Cell/Cord Blood Banking Market
13.1. Indonesia Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Stem Cell/Cord Blood Banking Market
14.1. South Korea Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Stem Cell/Cord Blood Banking Market
15.1. Western Europe Stem Cell/Cord Blood Banking Market Overview
15.2. Western Europe Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Stem Cell/Cord Blood Banking Market
16.1. UK Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Stem Cell/Cord Blood Banking Market
17.1. Germany Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Stem Cell/Cord Blood Banking Market
18.4. France Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Stem Cell/Cord Blood Banking Market
19.1. Eastern Europe Stem Cell/Cord Blood Banking Market Overview
19.2. Eastern Europe Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Stem Cell/Cord Blood Banking Market
20.1. Russia Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Stem Cell/Cord Blood Banking Market
21.1. North America Stem Cell/Cord Blood Banking Market Overview
21.2. North America Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Stem Cell/Cord Blood Banking Market
22.1. USA Stem Cell/Cord Blood Banking Market Overview
22.2. USA Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Stem Cell/Cord Blood Banking Market
23.1. South America Stem Cell/Cord Blood Banking Market Overview
23.2. South America Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Stem Cell/Cord Blood Banking Market
24.1. Brazil Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Stem Cell/Cord Blood Banking Market
25.1. Middle East Stem Cell/Cord Blood Banking Market Overview
25.2. Middle East Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Stem Cell/Cord Blood Banking Market
26.1. Africa Stem Cell/Cord Blood Banking Market Overview
26.2. Africa Stem Cell/Cord Blood Banking Market, Segmentation by Cell Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Stem Cell/Cord Blood Banking Market, Segmentation by Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Stem Cell/Cord Blood Banking Market Competitive Landscape and Company Profiles
27.1. Stem Cell/Cord Blood Banking Market Competitive Landscape
27.2. Stem Cell/Cord Blood Banking Market Company Profiles
27.2.1. AMAG Pharmaceuticals
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Cordlife
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Cryo-Cell International
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Esperite
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Americord Registry LLC
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Stem Cell/Cord Blood Banking Market29. Stem Cell/Cord Blood Banking Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aldagen
  • Arteriocyte
  • CordVida
  • Cytori Therapeutics
  • LifeCell International
  • Stem Cyte
Major players in the stem cell/cord blood banking market are AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, Esperite, and Americord Registry LLC.

The global stem cell/cord blood banking market is expected to grow from $8.16 billion in 2020 to $8.61 billion in 2021 at a compound annual growth rate (CAGR) of 5.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $12.51 billion in 2025 at a CAGR of 9.8%.

The stem cell/cord blood banking global market consists of sales of stem cell/cord blood banking services and related goods. Cord stem cells are referred to as regenerative medicines which help in regeneration of tissues or cells in the body. Stem cells therapy is designed to aid the physician in performing medical treatment of different types of cancers, neurodegenerative diseases, graft-versus-host disease and heart diseases.

The stem cell/cord blood banking market covered in this report is segmented by cell type into adult stem cells, umbilical cord blood stem cells, embryonic stem cells. It is also segmented by service into collection, processing, analysis, storage; by bank type into public, private and by application into leukemia, anemia, thalassemia, autism, cerebral palsy, diabetes, others.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Lack of awareness especially among pregnant women is a major restraint for the stem cell/cord blood banking market. This is mainly because a majority of pregnant women are unaware of the functioning of the public cord blood banks. Hence, this option is not fully explored despite the advantages of stem cell transplantation in treating cancer. For example, according to the survey by International Journal of Reproduction, Contraception, Obstetrics and Gynecology (IJRCOG), only 45% of pregnant women were informed about the uses of umbilical cord blood during pregnancy, just 5% were aware about the cost of the procedure and less than 1% were aware about the availability of cord blood banking.

Pairing of cord blood and tissue storage with genetic testing services is an emerging trend in the stem cell/cord blood banking market. Such pairing is possible and efficient because of its complimentary services to the existing clients, thereby helping in expanding their product portfolio. For example, genetic testing company Natera launched the Evercord cord blood and tissue storage service that enables expectant parents to collect, store and potentially retrieve their newborn's cord blood and tissue for therapeutic use in transplantation and regenerative medicine applications.

In September 2019, CBR, a California Cryobank Life Sciences company acquired Natera's Evercord cord blood and tissue banking business for an undisclosed amount. This acquisition will allow Natera to focus squarely on its core genetic testing business in reproductive health, oncology and organ transplantation. Natera Inc, a genetic testing company that operates a CLIA-certified laboratory in San Carlos, California.

Increasing number of cancer patients is a major driver for the stem cell /cord blood banking market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant in which the stem cells come from the same person who gets the transplant or by allogeneic transplant in which means the stem cells come from a matched related or unrelated donor. By using stem cells in the treatment of cancer, the blood forming stem cells which are damaged during chemotherapy can be restored. According to the American Cancer Society, in 2019, around 606,880 deaths were caused in USA due to prevalence of the cancer which can be treated by transplanting the stem cells.

The US Food and Drug Administration (FDA) outlines guidance related to stem cells/cord blood banking in accordance with section 212 of the Small Business Regulatory Enforcement Fairness Act (Public Law 104-121). As per this act, stem cells sourced from cord blood for unrelated allogeneic use are regulated by the FDA, and, in order to distribute these products, distributors need to get a license from the FDA. These licenses are provided by the FDA after reviewing the manufacturing and the storage conditions. In this regard, the American Association of Blood Banks (AABB) and other regulatory agencies also work with the FDA. Hence, the regulatory scenario related to the stem cells/cord blood banking market is expected to keep a check on companies involved in this market.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite
  • Americord Registry LLC
  • China Cord Blood Corporation
  • Cordlife Group Limited
  • CordVida
  • ESPERITE N.V.
  • Cryo Stemcell
  • Lifecell
  • PerkinElmer
  • Reelabs
  • Smart Cells International
  • Stemade Biotech
  • StemCyte
  • ViaCord
  • Americord
  • LifeCell International
  • Cryoviva India
  • Cytori Therapeutics
  • Thermo Fisher Scientific
  • Cord Blood America Inc.
  • Stem Cyte
  • Aldagen
  • Arteriocyte
  • Brainstorm Cell Therapeutics
Note: Product cover images may vary from those shown

Loading
LOADING...